Scenario | 2009 | 2011 |
---|---|---|
1: Gluco-corticoid explanation | 10/21 did not mention risk of adrenal suppression; 6/21 did not say the risk-benefit ratio favored taking steroids | 16/19 did not mention risk of adrenal suppression; 4/19 did not say the risk-benefit ratio favored taking steroids |
2: Joint injection preparation | 11/21 did not prepare the injection sterilely; 12/21 did not buffer the lidocaine | Scenario not used |
3: Joint injection explanation and simulation | All fellows were respectful of parent’s concerns; 13/21 did not mention skin hypopigmentation as a side effect | All fellows were respectful of parent’s concerns; 12/19 did not mention skin hypopigmentation as a side effect |
4: Musculo-skeletal exam | Of all assessed joints, none was examined by all 21 fellows; 7/21 fellows did not check forefoot | The wrist was the only joint examined by all 19 fellows; 8/19 fellows did not check forefoot |
5: Dermato-myositis diagnosis discussion | 11/21 did not mention possibility of abdominal pain; 14/21 did not mention possible emotional consequences of JDM | 12/18 did not mention possibility of abdominal pain; 14/18 did not mention safety precautions necessary due to muscle weakness |
6: Juvenile arthritis lecture | 9/21 did not mention limb growth abnormalities; 11/21 did not mention jaw disease related to oligoarticular juvenile arthritis | 10/19 did not mention limb growth abnormalities; 13/19 did not mention jaw disease related to oligoarticular juvenile arthritis |
7: Insurance appeal | 10/21 did not cite a source correctly for the letter; 10/21 did not describe patient consequences of denied treatment | Scenario not used |
8: Gait analysis | Scenario not used | Not scored |
9: Bad news delivery | Scenario not used | All 18 fellows were respectful of the parent; 11/18 did not ask how much information the parent wanted to know about cancer |